Skip to Content
Merck
  • Neuropathic mechanisms in the pathophysiology of burns pruritus: redefining directions for therapy and research.

Neuropathic mechanisms in the pathophysiology of burns pruritus: redefining directions for therapy and research.

Journal of burn care & research : official publication of the American Burn Association (2012-11-09)
Ioannis Goutos
ABSTRACT

Pruritus in burn wounds is a common symptom affecting patient rehabilitation. Over the last decades, there has been a resurgence of interest into more effective strategies to combat this distressing problem; nevertheless, no reports exist in the literature to propose pathophysiological mechanisms responsible for the generation and persistence of pruritic symptoms in the late phases of burns rehabilitation. Neuronal pathways mediating pruritic and painful stimuli share striking similarities, which allows the comparative exploration of the less extensively studied pruritic mechanisms using pain models. Furthermore, emerging anatomical, neurophysiological, and pharmacological evidence supports the involvement of neuropathic mechanisms in chronic burns pruritus. This work updates the conceptual framework for the pathophysiology of burns itch by embracing the contribution of the central nervous system in the maintenance of symptoms into a chronic state. The proposed pathophysiological model paves new avenues in burns pruritus research and is likely to have implications in the quest for more effective therapeutic regimens in clinical practice.

MATERIALS
Product Number
Brand
Product Description

Supelco
Ondansetron Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ondansetron hydrochloride dihydrate, ≥98% (HPLC), powder
Ondansetron hydrochloride dihydrate, European Pharmacopoeia (EP) Reference Standard
Ondansetron for TLC system suitability, European Pharmacopoeia (EP) Reference Standard
Ondansetron for LC system suitability, European Pharmacopoeia (EP) Reference Standard